These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 17265022

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K.
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.
    Di Carlo E, Bocca P, Emionite L, Cilli M, Cipollone G, Morandi F, Raffaghello L, Pistoia V, Prigione I.
    Mol Ther; 2013 May; 21(5):1034-43. PubMed ID: 23481325
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.
    Benzaïd I, Mönkkönen H, Stresing V, Bonnelye E, Green J, Mönkkönen J, Touraine JL, Clézardin P.
    Cancer Res; 2011 Jul 01; 71(13):4562-72. PubMed ID: 21646473
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy sensitizes colon cancer initiating cells to Vγ9Vδ2 T cell-mediated cytotoxicity.
    Todaro M, Orlando V, Cicero G, Caccamo N, Meraviglia S, Stassi G, Dieli F.
    PLoS One; 2013 Jul 01; 8(6):e65145. PubMed ID: 23762301
    [Abstract] [Full Text] [Related]

  • 13. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
    Izumi T, Kondo M, Takahashi T, Fujieda N, Kondo A, Tamura N, Murakawa T, Nakajima J, Matsushita H, Kakimi K.
    Cytotherapy; 2013 Apr 01; 15(4):481-91. PubMed ID: 23391461
    [Abstract] [Full Text] [Related]

  • 14. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.
    Todaro M, D'Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, Orlando V, La Mendola C, Gulotta G, Salerno A, Dieli F, Stassi G.
    J Immunol; 2009 Jun 01; 182(11):7287-96. PubMed ID: 19454726
    [Abstract] [Full Text] [Related]

  • 15. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
    Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pintière C, Daniel P, Genetet N, Meunier B, Dupont-Bierre E, Boudjema K, Catros V.
    Cancer Immunol Immunother; 2008 Apr 01; 57(4):531-9. PubMed ID: 17764010
    [Abstract] [Full Text] [Related]

  • 16. Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma.
    Sun L, Li Y, Jiang Z, Zhang J, Li H, Li B, Ye Z.
    Tumour Biol; 2016 Jun 01; 37(6):7333-44. PubMed ID: 26676633
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.
    Nicol AJ, Tokuyama H, Mattarollo SR, Hagi T, Suzuki K, Yokokawa K, Nieda M.
    Br J Cancer; 2011 Sep 06; 105(6):778-86. PubMed ID: 21847128
    [Abstract] [Full Text] [Related]

  • 18. In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement.
    Benzaïd I, Mönkkönen H, Bonnelye E, Mönkkönen J, Clézardin P.
    Clin Cancer Res; 2012 Nov 15; 18(22):6249-59. PubMed ID: 23032740
    [Abstract] [Full Text] [Related]

  • 19. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma].
    Li Z, Tang J, Sun L, Ye Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan 15; 29(1):6-9. PubMed ID: 23294710
    [Abstract] [Full Text] [Related]

  • 20. Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells.
    Okuno D, Sugiura Y, Sakamoto N, Tagod MSO, Iwasaki M, Noda S, Tamura A, Senju H, Umeyama Y, Yamaguchi H, Suematsu M, Morita CT, Tanaka Y, Mukae H.
    Front Immunol; 2020 Jan 15; 11():1405. PubMed ID: 32793196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.